Gastrointestinal Cancer News

Metabolic syndrome appeared associated with an increased risk for esophageal adenocarcinoma among elderly patients, study data showed.

Researchers found through long-term follow-up that patients with hepatitis C virus infection who achieved sustained virologic response after interferon-based therapy were still at risk for hepatocellular carcinoma, more specifically older patients and those with cirrhosis.

SuperSonic Imagine announced the FDA granted 510(k) clearance to add additional imaging probes — for liver disease and breast lesions — for use with its Aixplorer platform.

Mail outreach strategies were effective for increasing screening rates for hepatocellular carcinoma among patients with cirrhosis, a population most at-risk, according to data from a recent prospective study.

Survivors of prior malignancies who develop chronic myeloid leukemia may have the same outcomes with tyrosine kinase inhibitors as patients with CML and no prior malignancies, according to research published in Cancer.

Using a non-endoscopic device touted as a “sponge-on-a-string” test, researchers were able to identify patients with Barrett’s esophagus who have a low risk for progression to esophageal cancer, allowing them to avoid endoscopic evaluation.

The FDA granted orphan drug designation to AM0010 for the treatment of pancreatic cancer.

BOSTON — Opdivo monotherapy was safe and effective in patients with advanced hepatocellular carcinoma, irrespective of infection status, according to results of the CheckMate 040 trial presented during a Late Breaker at The Liver Meeting 2016.

With over 9,000 newly-diagnosed patients each year, pancreatic cancer is the only major cancer with a 5-year survival rate below 10%, at only 8%, according to Pancreatic Cancer Action Network.

Nov. 17 is the American Cancer Society’s Great American Smokeout. The annual event, held on the third Thursday of each November, is geared towards getting smokers to plan to quit.